• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    FDA Approves First Nasal Rescue Treatment for Frequent Seizure Activity

    Lens-Free Microendoscope Generates High Quality Images

    Roche's Blood Glucose Reading Smartphone App Gains CE Mark

    FDA BDP Designation for the iLet Bionic Pancreas System

    NeuMoDx Molecular and Sentinel Diagnostics Partner
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    From Genome Sequencing to the World’s First Portable MRI

    An Update on Digital Health

    ‘If You’re Reading This, You Need to Be at This Meeting’

    Five Steps for Succeeding Globally in Medtech

    Unlocking Market Doors with Real-World Evidence
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Accumold

    RJG Inc.

    Lyons

    Nelson Laboratories LLC

    FUTEK Advanced Sensor Technology Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Sounding Board: Looking Back at 2019 and Gazing at 2020

    Understanding Key Processes for Mixing APIs with Silicone

    How to Minimize Color Variations in Your Medical Device

    Don’t Touch: Gesture Tech Is Reshaping How We Interact with Devices

    Revenue-Based Financing: A New Form of Growth Capital
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Nelson Laboratories LLC

    Zeus

    MicroLumen Inc.

    Glenbrook Technologies Inc.

    DELMIAWORKS (IQMS)
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Enthusiastic Leadership at AdvaMed

    Enthusiastic Leadership at AdvaMed
    Related CONTENT
    • AdvaMed Names VP of Alliance Development
    • Making Medical Wearables Clinically Relevant
    • A Medtech Horror Story
    • New Year’s Resolutions for Industry
    • AdvaMed and MassMEDIC: Two Meetings You Should Attend in 2017
    Sean Fenske, Editor01.30.17
    My first experience at an AdvaMed event years ago found me in Washington, D.C., for the association’s annual meeting. While informative, the feel of the event was a bit “stuffy,” with a heavy focus on regulatory concerns and legislative issues. Fast-forward to the 2015 event in San Diego, Calif., and the difference was significant. While those “stuffy” issues were still a topic of discussion during several sessions, the event felt like more of a celebration of innovation in medtech with speakers painting a very positive image of the industry. This was a bit of a contrast to the less-than-enthusiastic opinions of the then yet-to-be-suspended device excise tax, which was at the top of many attendees’ minds.

    During that 2015 event, I had the pleasure of being introduced to the then board chairman of AdvaMed Accel, a division of the association focused on addressing the needs of smaller medtech companies. That person was Nadim Yared, president and CEO of one of those smaller firms himself—CVRx Inc. CVRx developed the Barostim neo, a minimally-invasive implantable system and the only device CE-marked for the separate indications of heart failure and resistant hypertension.

    Yared was an outspoken “cheerleader” of sorts for the industry at the event; his enthusiasm for medtech was apparent each time he spoke. For that reason, at the 2016 meeting, I was excited to hear of the new role Yared would be undertaking within AdvaMed. Starting in March 2017, he will serve as AdvaMed’s chairman of the board for a term of two years. One would be challenged to find a more vocal proponent of the medtech industry to lead the organization.

    In the following interview, MPO was able to speak with Yared about his upcoming role, challenges facing the industry, and what he saw on the horizon for the medical device sector.

    Sean Fenske: Can you share a bit of your background within the medical device industry?
    Nadim Yared: Sure. From the outset, I’ve had the privilege to work for both small and large companies. Ten years ago, I joined CVRx, leaving Medtronic where I had been serving as vice president and general manager of Medtronic Navigation. Medtronic Navigation was one of the best-kept secrets within the company: a cool group of advanced researchers based in Boulder, Colo., developing smart surgical tools utilizing the latest imaging and digital localization technologies.

    Prior to that, I worked at GE Medical for 10 years in both engineering and marketing roles. After graduating with an engineering degree, I joined GE to develop the software-based CT/MR/X-ray digital console and 3D-image reconstruction platform. After I received an M.B.A. from Insead in France, I moved into marketing to lead GE’s surgical imaging business. In that role, I identified OEC Medical Systems as a good acquisition target, and upon its acquisition, moved my family to Salt Lake City, Utah, to lead the integration efforts.

    I’ve had the opportunity to work with a wide variety of stakeholders globally who have an interest in our industry—suppliers, investors, and the lawmakers whose work impacts all of our businesses, but most importantly, the patients we serve. Since 2011, I have served on AdvaMed’s Board of Directors, where I have witnessed firsthand the importance of taking an active role in working with members of Congress and the federal agencies with oversight of our industry to ensure that safe and effective innovative technologies reach those patients that need them most.

    Fenske: You’ll be the first “small company” representative to serve as chairman of the board of AdvaMed. Why is this significant?
    Yared:
    Approximately 75 percent of AdvaMed’s active members are small companies—those with annual U.S. revenue of less than $100 million. AdvaMed also represents the largest multi-national corporations in medtech. My nomination to this role only confirms the broader industry’s commitment to small-cap company issues and concerns, a message AdvaMed has been working to drive home for years. I’m looking forward to working with the industry as a whole to address the challenges we all face and strengthening the innovation ecosystem.

    Fenske: Speaking of those small-cap companies, at one time, there was a bit of a perception of AdvaMed serving more of the bigger industry players. What has AdvaMed done to be more inviting to the entire medical device industry, both small and large firms alike?
    Yared:
    In 2012, AdvaMed Accel was established to focus on our small company members—the majority of these being pre-revenue companies. This division has taken off, and we are observing an increase in both retention and the number of new, small-company members. We’ve worked hard as an organization to ensure the voices of all member companies are heard through our advocacy efforts and to ensure we are providing the appropriate information and opportunities for our companies. We’ve also created new sectors, including radiation therapy and most recently, AdvaMed Digital, to ensure we are supporting the needs of our diverse membership, dynamic ecosystem, and those companies moving into healthcare.

    Also, we’ve expanded leadership and diversity on AdvaMed’s various boards—including through the Women’s Executive Network—and established a more unified voice in talking with key government agencies and lawmakers. There is strength in numbers, and we’re working hard to ensure that we are unified as an industry in Washington, D.C., and beyond.

    Fenske: Last year at the annual meeting, AdvaMed announced a group purchasing program, which would likely most benefit those smaller firms. Can you share the details of that?
    Yared:
    The purpose of the AdvaMed Purchasing Group is to improve the quality and reduce the acquisition costs of products and services required by our members to run their operations by providing members with collective purchasing resources (the member-driven consortium) needed to continue to thrive. The AdvaMed Purchasing Group is supporting the innovation ecosystem by allowing our smaller members to divert resources from procurement to those needed to bring innovations to market. AdvaMed Accel members in particular are finding that their procurement savings exceed the amount they pay in annual membership dues to AdvaMed.

    Our members are now saving significant dollars through pre-negotiated contracts with leading suppliers of commonly used business services, strengthening their bottom line. As you mention, small and medium-sized companies are saving the most through this program as they are able to take advantage of supplier rates generally reserved only for the largest companies.

    Fenske: What about your company. Is CVRx participating in the group purchasing program?
    Yared:
    Yes, CVRx is personally benefiting from the program. To give you one specific example, our team had our buyer do a sampling of some key items that we buy and what we think we will see for savings in this program. We sampled our most frequently purchased items and looked at 15 in total. The price was better on eight of the items and no items were higher than our current pricing. The average savings as a percentage on the eight items was 33 percent. And this was just on one of the contracts.

    Fenske: That sounds fantastic. How has the program been received by the industry since the announcement?
    Yared:
    AdvaMed has received significant interest in the purchasing group since it officially launched in October at AdvaMed 2016. Member companies have begun enrolling in the program and dozens more are in active discussions with multiple suppliers.

    Fenske: Getting back to your role as the next chairman of the board of AdvaMed, what issues are most significant to you that you will seek to address first?
    Yared:
    What’s most significant to the industry is to ensure that we protect and provide fertile ground for the innovation ecosystem to continue to grow and blossom, creating more needed therapies and high-paying jobs. This will include working with the new administration on policies to protect and grow our ecosystem, particularly with regard to payment and coverage policies, regulatory pathways, trade, and capital formation. As mentioned previously, I look forward to continuing to develop and unify the voice of our industry in Washington, D.C., and worldwide.

    Fenske: Speaking of the incoming administration, how are efforts proceeding with support to repeal the device tax? Do you think with the result of the presidential election, we will likely see its demise as a permanent solution?
    Yared:
    AdvaMed strongly urges Congress and the new administration to move quickly on permanent repeal of the medical device excise tax. Solid bipartisan majorities in both the House and Senate are already on record in favor of repealing this anti-jobs, anti-patient, and anti-innovation tax, and both chambers strongly supported the two-year suspension that went into effect in January 2016. Since the suspension took effect, medical technology companies have been able to reinvest those resources into new hiring, R&D, and capital improvements. This benefits patients, the economy, and American innovation. We are calling on the 115th Congress to fully repeal this tax as early as possible in this new year, so companies can plan longer term to ensure these benefits continue.

    Fenske: Focusing more specifically, what did the device tax suspension mean for your own company—CVRx? Were those funds reinvested into R&D or personnel, or did it have some other impact on the company?
    Yared:
    In the U.S., our product is not yet fully approved by the FDA, so the medical device excise tax’s direct impact on CVRx was limited. However, we believe that the suspension of the tax created a positive environment that allowed CVRx to raise its latest round of financing that was needed to develop the evidence required for FDA approval in the U.S.

    Translating device breakthroughs into commercial products often requires the help of a larger firm. But thanks to the tax, larger firms have less money with which to acquire promising companies. With only a short window of suspension, companies cannot fully take advantage of the extra cash on hand due to the uncertainty of the future with regard to this tax. Repealing the device tax will provide medical technology innovators with the long-term certainty necessary to support future job growth and sustainable, cutting-edge R&D that will ultimately lead to the next generation of breakthroughs in patient care and treatment.

    Fenske: Overall, what’s your outlook on the industry in the years ahead? What key issues do we face and what can we expect?
    Yared:
    As for key issues impacting the industry in the coming years, I think we are going to see continued progress on the regulatory front. FDA has made great strides in improving the timeliness, predictability, and transparency of its review processes under the current user fee agreement. The reforms included in the recently enacted 21st Century Cures Act combined with the robust performance goals and additional process improvements in the MDUFA IV agreement negotiated between industry and the agency in 2016 will continue the trend of steady progress at the agency. That’s good for FDA, innovation, and, most importantly, patients.

    On the reimbursement front, we have some work to do to mirror the progress we’ve seen at FDA. We often discuss as an industry—including companies of all sizes and the VC community—the challenges of navigating the complex coding, coverage, and payment processes at CMS. There is much the agency can do to improve the consistency and transparency of its processes to help ensure that all beneficiaries have timely access to the innovative technologies they need. We look forward to working with the new administration on pro-patient, pro-innovation polices that recognize the value medical technology provides as part of the solution to the healthcare challenges we face.

    Fenske: Before we wrap up, do you have any closing comments you’d like to share?
    Yared:
    AdvaMed has worked—and continues to work—diligently to serve the needs of smaller companies, in particular with regard to capital formation and to support the innovation ecosystem. This effort requires the entire industry to come around and work together. There is no company too small to be a member of AdvaMed. There are many benefits to joining AdvaMed now: member companies benefit from the savings provided by the AdvaMed Purchasing Group; executives are provided ample opportunities to network with their peers of all sizes of companies; member companies have an ability to influence key policies; and last but not least, member companies can unite their voices, ensuring that our industry is heard clearly in Washington and beyond. 
    Related Searches
    • user
    • innovation
    • ct
    • supplier
    Related Knowledge Center
    • Software & IT
    Suggested For You
    New 510(k) Approach Would Leverage FDA Objective Criteria New 510(k) Approach Would Leverage FDA Objective Criteria
    AdvaMed Unveils Frameworks for Assessing Value of MedTech and Diagnostics AdvaMed Unveils Frameworks for Assessing Value of MedTech and Diagnostics
    Industry Offers Support for Gottlieb Confirmation Industry Offers Support for Gottlieb Confirmation
    Give and Take with the Tech Industry Give and Take with the Tech Industry
    The MedTech Conference Partners with Medical Device Manufacturers Association The MedTech Conference Partners with Medical Device Manufacturers Association
    A Legal Eye’s View of Medtech M&A A Legal Eye’s View of Medtech M&A
    Mike on Medtech: Device Incident Reporting Mike on Medtech: Device Incident Reporting
    AdvaMedDx Statement on the Diagnostic Accuracy and Innovation Act AdvaMedDx Statement on the Diagnostic Accuracy and Innovation Act
    AdvaMed Names New Chairman of the Board of Directors AdvaMed Names New Chairman of the Board of Directors
    Collaborative R&D Collaborative R&D
    A Review of Sustaining Engineering in Medtech A Review of Sustaining Engineering in Medtech
    Bringing Imaging to the Cloud Bringing Imaging to the Cloud
     MedTech Industry Lost Nearly 29,000 Jobs While Device Tax In Effect MedTech Industry Lost Nearly 29,000 Jobs While Device Tax In Effect
    Dependable Data Dependable Data
    AdvaMed and MassMEDIC: Two Meetings You Should Attend in 2017 AdvaMed and MassMEDIC: Two Meetings You Should Attend in 2017

    Related Columns

    • Software & IT
      Unlocking Market Doors with Real-World Evidence

      Unlocking Market Doors with Real-World Evidence

      Real-world evidence is becoming increasingly important for manufacturers to demonstrate value beyond efficacy and safety standards.
      Seth Goldenberg, Ph.D., Vice President, Vault Medical Device & Diagnostics, Veeva Systems 11.04.19

    • Contract Manufacturing | Software & IT
      Five Ways Quality 4.0 Is Changing the Face of Medical Device Manufacturing

      Five Ways Quality 4.0 Is Changing the Face of Medical Device Manufacturing

      Industry 4.0 represents the dawn of the digital transformation that began with the third revolution, connecting the physical and natural worlds.
      Scott Reedy, Senior Director of Marketing, Arena Solutions 10.08.19

    • Contract Manufacturing | Digital Health | Software & IT
      Connecting the Dots in Medical Device Outsourcing

      Connecting the Dots in Medical Device Outsourcing

      San Francisco is globally renowned for many things: The Golden Gate Bridge (its color, international orange, was actually a primer used to protect the steel during transit), Ghirardelli chocolate, the TransAmerica pyramid building, and the “Pai…
      MPO Staff 07.30.19


    • Software & IT
      Five Strategies to Navigate Regulatory Challenges in Medical Device Development

      Five Strategies to Navigate Regulatory Challenges in Medical Device Development

      Medical device products are rapidly evolving to become more personalized and connected, leveraging artificial intelligence (AI), robotics, and mobile technology. Against this backdrop of continual innovation, medical device manufacturers face uniq…
      Seth J. Goldenberg, Ph.D., Vice President, Vault Medical Device & Diagnostics, Veeva Systems 07.30.19

    • Software & IT
      Connected Quality Systems Reduce Risks

      Connected Quality Systems Reduce Risks

      For the best outcome in medical design innovation with highly outsourced teams, having a rock-solid approach to quality is a prerequisite. As regulatory standards, market requirements, and device complexities have evolved, so too has the weight of th…
      Scott Reedy, Senior Director of Marketing, Arena Solutions 06.13.19

    • Software & IT
      Using Digitization to Get Ahead in Medtech

      Using Digitization to Get Ahead in Medtech

      Companies developing cutting-edge medical devices need cutting-edge technology for their business processes. Whether a company focuses on finding new device materials, designing non-invasive monitors, or tackling the regulatory process, medtech is ad…
      Bryant Headley, Customer Success Executive, MasterControl 05.01.19


    • Software & IT
      Quality Systems: It’s All Greek to Us

      Quality Systems: It’s All Greek to Us

      I admire people who love what they do. There’s a lot of truth to the oft-quoted Mark Twain observation: “Find a job you enjoy doing, and you will never have to work a day in your life.” For the most part, that applies to me. But…
      Dawn A. Lissy, President & Founder, Empirical 04.03.19

    • Software & IT
      Five Questions to Improve Your Requirements Management

      Five Questions to Improve Your Requirements Management

      Medical device developers spend years designing devices that help improve patient outcomes, which leads to millions of dollars invested in product development. If risk and requirements are not managed properly during development, it could result in a…
      Kevin Steigerwald, VP of Product & UX, Jama Software 04.03.19

    • Software & IT
      Digital Transformation: Seven Considerations for Your QMS

      Digital Transformation: Seven Considerations for Your QMS

      Increasing numbers of companies are investing in digital transformation to gain a competitive edge, with digitization set to more than double among manufacturers since 2016 according to Forbes. It’s all part of a rapid technological acceleratio…
      Tony Parise, Product Strategist—Life Sciences, ETQ 04.03.19


    • Software & IT
      Three Questions to Master Continual MDSAP Conformity

      Three Questions to Master Continual MDSAP Conformity

      Product recalls frequently make headlines and tarnish brand reputations as a result. In today’s digital world, one bad customer experience with quality can be broadcast in seconds, giving brands little time to react. Not prioritizing quality is…
      Tony Parise, Product Strategist—Life Sciences, ETQ 03.07.19

    • R&D & Design | Software & IT
      Disrupting the Outsourcing Model

      Disrupting the Outsourcing Model

      The rise and relative success of companies dealing in cloud-based systems has revolutionized how we handle data. This is prompting a shift away from traditional software, hardware, and legacy systems, and enabling companies in new and unexpected ways…
      Steve Maylish and Shannon White, Fusion Biotec 01.31.19

    • Software & IT
      4 Ways to Prepare for the European Medical Device Regulation (MDR)

      4 Ways to Prepare for the European Medical Device Regulation (MDR)

      The new Medical Device Regulation (MDR) is changing the rules for medical device manufacturers and distributors selling and marketing in Europe. The MDR replaces the current Medical Devices Directive (MDD) and goes into effect in less than 18 months.…
      Melonie Warfel, Vice President, Medical Device & Diagnostics, Veeva Systems 01.30.19

    • Software & IT
      Organizational and Regulatory Influences on Creating and Sustaining an Effective QMS

      Organizational and Regulatory Influences on Creating and Sustaining an Effective QMS

      A quality management system (QMS) is a fundamental regulatory requirement for any medical device company that needs to sell or introduce medical devices to the market. The risks associated with not having a robust QMS include making a non-conforming…
      Annette Schaps, Schaps Consulting, and Chuck Cimalore, Arena Solutions 11.26.18

    • Software & IT
      How to Choose the Right Quality Management System

      How to Choose the Right Quality Management System

      Beyond the requirement for medical device companies, having a quality management system (QMS) provides a framework to deliver consistency and efficiency in a business. The two main regulations requiring a QMS are FDA 21 CFR 820 (U.S.) and ISO 13485 (…
      Chuck Cimalore and Rasean Hamilton, Omnify Software and EarLens 09.07.18

    • Software & IT
      Digitalization of the QMS: 15 Years of Evolution

      Digitalization of the QMS: 15 Years of Evolution

      Quality management has been a concept from the first time people created goods—higher quality goods represented higher status in society. Since then, the way we create, distribute, and evaluate goods has changed drastically. Factory producti…
      Alexa Sussman, Content Marketing Writer, EtQ 06.04.18


    Breaking News
    • FDA Approves First Nasal Rescue Treatment for Frequent Seizure Activity
    • Lens-Free Microendoscope Generates High Quality Images
    • Roche's Blood Glucose Reading Smartphone App Gains CE Mark
    • FDA BDP Designation for the iLet Bionic Pancreas System
    • NeuMoDx Molecular and Sentinel Diagnostics Partner
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Adding Fabrication Capabilities: Additive Manufacturing for Production Parts
    • Delivering the Goods: The Evolving World of Combination Products
    • Anxious Undertones: The 2019 Year in Review
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Palmer Holland Expands Sales Team into Canada
    Axalta Reports 'Oustanding' Feedback on Award-Winning Voltatex 4224
    Sika Opens 3rd Indonesian Plant
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA Approves First Nasal Rescue Treatment for Frequent Seizure Activity
    Lens-Free Microendoscope Generates High Quality Images
    Roche's Blood Glucose Reading Smartphone App Gains CE Mark
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Charles River, Bit Bio Enter Strategic Partnership
    Parexel Adds Experts to Regulatory Consulting Group
    Catalent, Bridge Therapeutics Execute Exclusive License Agreement
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Star of E!'s Botched Gets Line Leaping Bunny Certified
    Verve Medical Cosmetics Celebrates 20 Years
    Happi

    Latest Breaking News From Happi

    Jennifer Garner Joins Virtue Labs
    Perfect Corp. Partners with Sally Beauty
    Dollar General To Sell CBD Beauty
    Ink World

    Latest Breaking News From Ink World

    ePac Flexible Packaging Expands into Asia Pacific Market
    Palmer Holland Expands Sales Team into Canada
    Koenig & Bauer Promotes Preston Neetzel to Director of Flexo Sales
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Domino welcomes Steve Daily to Service & Support Team
    Kodak and Uteco sell first Ultrastream flexible packaging press
    Archroma announces CEO transition
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    AATC Adds Two Scholarships
    Archroma Names CEO
    Fitesa Buys Freudenberg's South American Hygiene Business
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System
    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application
    Tyber Medical Opens $8M Office and Manufacturing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Ynvisible, Identiv Partner
    Tom Peregoodoff Appointed CEO of TF Massif Technologies
    Osram’s Managing Board Invites ams to Talks About Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.